Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Ozempic, Wegovy may be linked to risk of rare form of blindness: Study

by
July 3, 2024
in Health Care
0
Ozempic, Wegovy may be linked to risk of rare form of blindness: Study

Those who take Ozempic or Wegovy may have an increased risk of developing a rare form of blindness, though future research is needed to make a final determination, researchers in a new study said.

The study, published Wednesday in the medical journal JAMA Ophthalmology, analyzed more than 16,800 people in the Boston area from the past six years, none of whom initially had the eye condition, called nonarteritic anterior ischemic optic neuropathy (NAION).

NAOIN occurs when there is a loss of blood flow to the optic nerve that typically causes vision loss in one way. Visual loss usually does not get significantly better or worse once it occurs.

Researchers looked specifically at a subgroup of about 1,700 patients who were overweight or obese or had diabetes, and compared the frequency of NAION in those who were prescribed semaglutide, the ingredient in Ozempic and Wegovy, to those who were not.

Ozempic and Wegovy are both typically used for those with Type 2 diabetes or for weight management.

Out of the 194 patients with Type 2 diabetes who took semaglutide, 17 eventually developed NAION over the course of the 36 months researchers observed, per the study. This rate of diagnosis was more than four times higher than those who were not prescribed semaglutide.

Of those with obesity who took semaglutide, 20 people developed NAION — eight times more than those who did not take semaglutide drugs.

Researchers noted the study suggests an association between semaglutide and NAION, but since it was an observation study based on data already existent, future research is needed to determine if semaglutide causes the eye condition.

Novo Nordisk, the maker of the only semaglutide medications in the U.S., noted the study is a single, observational study that cannot determine a causal relationship between NAION and semaglutide.

“Patient safety is a top priority for Novo Nordisk, and we take all reports about adverse events from use of our medicines very seriously,” a spokesperson for Novo Nordisk wrote to The Hill.

NAION “is not an adverse drug reaction for the marketed formulations of semaglutide … as per the approved labels,” the spokesperson added.

Previous Post

White House says gender-affirming surgeries should be limited to adults

Next Post

Abortion measures could be on the ballot in Arizona, Nebraska after organizers submit signatures

Next Post
Abortion measures could be on the ballot in Arizona, Nebraska after organizers submit signatures

Abortion measures could be on the ballot in Arizona, Nebraska after organizers submit signatures

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025
    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    June 27, 2025
    Unusual pushback, ‘dangerous precedent’: What the first meeting of Kennedy’s CDC advisers reveals about the future of vaccines in America

    Unusual pushback, ‘dangerous precedent’: What the first meeting of Kennedy’s CDC advisers reveals about the future of vaccines in America

    June 27, 2025

    Trending

    Study finds rare vision issues in taking GLP-1 weight loss drugs

    Study finds rare vision issues in taking GLP-1 weight loss drugs

    February 12, 2025
    Judge orders EPA to address potential IQ impacts of fluoride in drinking water

    Judge orders EPA to address potential IQ impacts of fluoride in drinking water

    September 25, 2024
    Exercise cuts heart disease risk in part by lowering stress, study finds

    Exercise cuts heart disease risk in part by lowering stress, study finds

    May 16, 2024
    How to understand COVID-19-related loss of smell

    How to understand COVID-19-related loss of smell

    May 23, 2024

    Recent News

    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025
    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    June 27, 2025

    Popular News

    • FDA expanding COVID vaccine warnings over rare heart side effect
    • Supreme Court upholds HHS authority over ObamaCare preventative care task force

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.